Article thumbnail

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

By Ondrej Slaby, Jana Jancovicova, Radek Lakomy, Marek Svoboda, Alexandr Poprach, Pavel Fabian, Leos Kren, Jaroslav Michalek and Rostislav Vyzula
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2907341
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). Al-Ahmadie HA: Recent developments in the pathology of renal tumors: morphology and molecular characteristics of select entities. Arch Pathol Lab Med
  2. (2009). Bonmassar E: miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta
  3. (2010). Cao D: TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect. Front Biosci
  4. (2008). Croce CM: Emerging role of miR-106b-25/miR17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res
  5. (2006). Croce CM: MicroRNA expression and function in cancer. Trends Mol Med
  6. (2009). Croce CM: MicroRNAs in Cancer. Annu Rev Med
  7. (2010). Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues.
  8. (2009). DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma. Klin Onkol
  9. (2009). Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet
  10. (2010). FF: Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res
  11. (2009). G: MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.
  12. (2008). Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol
  13. (2010). GM: Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem
  14. (2010). GM: The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
  15. (2010). HJ: Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis
  16. Kantoff PW: Renal Cell Carcinoma. In Holland-Frei Cancer Medicine 7th edition. Edited by: Kufe
  17. (2009). Kurie JM: Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev
  18. (2010). Liou LS: Identification of a microRNA panel for clear-cell kidney cancer. Urology
  19. (2007). Micro-RNA profiling in kidney and bladder cancers. Urol Oncol
  20. (2010). MicroRNA control of signal transduction.
  21. (2009). MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer
  22. (2006). Moses HL: Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer
  23. (2009). Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. Cancer
  24. (2006). Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer
  25. (2008). T: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep
  26. (2009). Tan TM: Role of the miR106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci
  27. (2009). Teh BT: MicroRNA profiling of human kidney cancer subtypes.
  28. (2009). Tsongalis GJ: MicroRNAs: novel biomarkers for human cancer. Clin Chem
  29. (2010). Volinia S: Non-coding RNAs: a key to future personalized molecular therapy? Genome Med
  30. (2009). Y: Differential expression of microRNA species in human gastric cancer versus nontumorous tissues.
  31. (2009). Zhang L: Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol